PubMed

Adalimumab in the therapy of uveitis in childhood.

Biester S, Deuter C, Michels H, Haefner R, Kuemmerle-Deschner J, Doycheva D, Zierhut M.

Br J Ophthalmol. 2007 Mar;91(3):319-24. Epub 2006 Oct 11.PMID: 17035274 [PubMed - indexed for MEDLINE]Related articles

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.PMID: 17049139 [PubMed - indexed for MEDLINE]Related articlesFree article

Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis.

Tynjälä P, Lindahl P, Honkanen V, Lahdenne P, Kotaniemi K.

Ann Rheum Dis. 2007 Apr;66(4):548-50. Epub 2006 Oct 26.PMID: 17068061 [PubMed - indexed for MEDLINE]Related articles

Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.

Foeldvari I, Nielsen S, Kümmerle-Deschner J, Espada G, Horneff G, Bica B, Olivieri AN, Wierk A, Saurenmann RK.

J Rheumatol. 2007 May;34(5):1146-50. Epub 2007 Mar 1.PMID: 17343318 [PubMed - indexed for MEDLINE]Related articles

Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.

Saurenmann RK, Levin AV, Rose JB, Parker S, Rabinovitch T, Tyrrell PN, Feldman BM, Laxer RM, Schneider R, Silverman ED.

Rheumatology (Oxford). 2006 Aug;45(8):982-9. Epub 2006 Feb 3.PMID: 16461435 [PubMed - indexed for MEDLINE]Related articlesFree article

Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis.

Tynjälä P, Kotaniemi K, Lindahl P, Latva K, Aalto K, Honkanen V, Lahdenne P.

Rheumatology (Oxford). 2008 Mar;47(3):339-44. Epub 2008 Jan 31.PMID: 18238789 [PubMed - indexed for MEDLINE]Related articles

Anti-TNF-alpha therapy in patients with chronic non-infectious uveitis: the experience of Jules Gonin Eye Hospital.

Petropoulos IK, Vaudaux JD, Guex-Crosier Y.

Klin Monbl Augenheilkd. 2008 May;225(5):457-61.PMID: 18454398 [PubMed - indexed for MEDLINE]Related articles

Retrospective case review of pediatric patients with uveitis treated with infliximab.

Rajaraman RT, Kimura Y, Li S, Haines K, Chu DS.

Ophthalmology. 2006 Feb;113(2):308-14. Epub 2006 Jan 10.PMID: 16406545 [PubMed - indexed for MEDLINE]Related articles

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.PMID: 16948890 [PubMed - indexed for MEDLINE]Related articlesFree article

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.

Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, Nemcova D, Mouy R, Sandborg C, Bohnsack J, Elewaut D, Foeldvari I, Gerloni V, Rovensky J, Minden K, Vehe RK, Weiner LW, Horneff G, Huppertz HI, Olson NY, Medich JR, Carcereri-De-Prati R, McIlraith MJ, Giannini EH, Martini A; Pediatric Rheumatology Collaborative Study Group; Pediatric Rheumatology International Trials Organisation.

N Engl J Med. 2008 Aug 21;359(8):810-20.PMID: 18716298 [PubMed - indexed for MEDLINE]Related articlesFree article

[Inhibitors of tumour necrosis factor-alpha for the treatment of arthritis and uveitis in childhood]

Heiligenhaus A, Horneff G, Greiner K, Mackensen F, Zierhut M, Foeldvari I, Michels H.

Klin Monbl Augenheilkd. 2007 Jun;224(6):526-31. Review. German. PMID: 17594625 [PubMed - indexed for MEDLINE]Related articles

Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.

Galor A, Perez VL, Hammel JP, Lowder CY.

Ophthalmology. 2006 Dec;113(12):2317-23. Epub 2006 Sep 25.PMID: 16996615 [PubMed - indexed for MEDLINE]Related articles

Do tumor necrosis factor inhibitors cause uveitis? A registry-based study.

Lim LL, Fraunfelder FW, Rosenbaum JT.

Arthritis Rheum. 2007 Oct;56(10):3248-52.PMID: 17907169 [PubMed - indexed for MEDLINE]Related articlesFree article

Etanercept and uveitis in patients with juvenile idiopathic arthritis.

Schmeling H, Horneff G.

Rheumatology (Oxford). 2005 Aug;44(8):1008-11. Epub 2005 Apr 26.PMID: 15855187 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.

Weisman MH, Moreland LW, Furst DE, Weinblatt ME, Keystone EC, Paulus HE, Teoh LS, Velagapudi RB, Noertersheuser PA, Granneman GR, Fischkoff SA, Chartash EK.

Clin Ther. 2003 Jun;25(6):1700-21.PMID: 12860493 [PubMed - indexed for MEDLINE]Related articles

Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis.

Tang B, Rahman M, Waters HC, Callegari P.

Clin Ther. 2008 Jul;30(7):1375-84.PMID: 18691998 [PubMed - indexed for MEDLINE]Related articles

Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.

Tynjälä P, Vähäsalo P, Honkanen V, Lahdenne P.

Ann Rheum Dis. 2009 Apr;68(4):552-7. Epub 2008 May 8.PMID: 18467515 [PubMed - indexed for MEDLINE]Related articles

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).

Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, Fischkoff SA, Chartash EK.

J Rheumatol. 2003 Dec;30(12):2563-71.PMID: 14719195 [PubMed - indexed for MEDLINE]Related articles

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.

Keystone EC, Kavanaugh AF, Sharp JT, Tannenbaum H, Hua Y, Teoh LS, Fischkoff SA, Chartash EK.

Arthritis Rheum. 2004 May;50(5):1400-11.PMID: 15146409 [PubMed - indexed for MEDLINE]Related articlesFree article

Etanercept and adalimumab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons leading to discontinuation of the treatment.

Levälampi T, Korpela M, Vuolteenaho K, Moilanen E.

Rheumatol Int. 2008 Jan;28(3):261-9. Epub 2007 Sep 6.PMID: 17846778 [PubMed - indexed for MEDLINE]Related articles